Storage is not strategy. Pharmaceutical organizations that treat data management as a storage problem — how to accumulate and preserve the largest possible volume of data — are building the wrong foundation for AI-driven drug discovery. The organizations seeing real AI results have moved beyond storage to something more architecturally demanding: a data fabric that […]
AI programs in pharmaceutical R&D fail for specific, architectural reasons. Understanding these failure modes before building is not theoretical caution — it is the difference between programs that produce actionable outputs and programs that consume budget without advancing drug development. This article documents the most common architectural constraints encountered in AI-driven discovery programs and maps […]
The pharmaceutical industry has invested heavily in artificial intelligence over the past decade. The results have been uneven — not because the models are inadequate, but because the data feeding those models is. In project after project, the root cause of AI failure in drug discovery is not model architecture. It is the quality, consistency, […]
Magnetic tape has been declared obsolete approximately once per decade since the 1980s. And yet, in 2026, tape remains in active operation across a substantial fraction of large enterprise environments—not for primary storage, where flash and disk have comprehensively won, but for long-term archival of compliance data, backup archives, and decades of accumulated historical records. […]
Before the Model Context Protocol (MCP), enterprise AI governance faced a fundamental architectural problem: AI agents accessed data through dozens of custom integrations, direct database connections, REST API calls, and SDK-based queries—each with its own authentication, its own data retrieval logic, and its own (usually absent) governance configuration. Enforcing consistent access controls, masking, lineage capture, […]
Enterprise AI agents cannot use data they cannot find. This statement is obvious—and it describes one of the most consistently underestimated barriers to enterprise AI production. Organizations spend heavily on model selection, vector databases, and inference infrastructure. They spend far less on the metadata management, catalog coverage, and semantic documentation that determines what fraction of […]
The EU AI Act represents the most comprehensive regulatory framework for artificial intelligence yet enacted. For enterprises operating in or serving European markets—which in practice includes most global enterprises—EU AI Act compliance is not a future concern. For high-risk AI categories, core obligations are already in force, with requirements expanding through 2027 under the Act’s […]
Every enterprise transformation initiative of the past decade has included “AI” somewhere in its vision statement. Very few have included a serious accounting of the data infrastructure transformation that AI production actually requires. The result is a growing gap between AI ambition and AI reality—a gap that is becoming more visible, more expensive, and more […]
In public discourse about AI competition, the moat conversation focuses almost entirely on model capability: who has the most parameters, the best benchmark scores, the fastest inference. In enterprise contexts, where AI must operate reliably in regulated environments, satisfy auditors, and scale across heterogeneous data estates, this framing is almost exactly backwards. The durable enterprise […]
The debate between Retrieval-Augmented Generation (RAG) and Cache-Augmented Generation (CAG) has absorbed more enterprise AI engineering attention than it probably deserves. Both are legitimate retrieval architectures with genuine tradeoffs. But the intensity of the RAG vs. CAG debate has created a distortion: it frames the enterprise AI challenge as an architecture selection problem when the […]
